Skip to main content

MYLAN CF 135 MYLAN CF 135 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint MYLAN CF 135 MYLAN CF 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Mylan Pharmaceuticals Inc.

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN CF 135 MYLAN CF 135

Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135
Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135
Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135

Fenofibric Acid Delayed-Release

Imprint
MYLAN CF 135 MYLAN CF 135
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, gelatin, hydroxypropyl cellulose, hypromelloses, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, povidone, sodium lauryl sulfate, sodium stearyl fumarate, magnesium silicate, titanium dioxide, triethyl citrate, ferric oxide yellow, FD&C Blue No. 2, ammonia, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2590 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0196 (Discontinued) UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.